Preoperative dietary restriction reduces hepatic tumor load by reduced E-selectin-mediated adhesion in mice
Journal of Surgical Oncology , Volume 102 - Issue 4 p. 348- 353
Background: Inflammatory responses facilitate metastasis by increasing expression of adhesion molecules. Dietary restriction (30% reduction in daily calorie intake) reduces the expression of adhesion molecules and protects against surgically induced inflammation. DR might therefore beneficially interfere with surgery-induced inflammation and subsequent adhesion of circulating tumor cells. Methods: BALB/c mice were subjected to 2 weeks dietary restriction prior to inoculation with tumor cells. Intra-splenic injection of 5.0 × 104C26-colon carcinoma cells was followed by splenectomy. Hepatic tumor load was scored after 10 days as a percentage (tumor surface/total liver surface) on H&E stained sections. Liver mRNA expression of adhesion molecules was determined and the effect of serum from dietary restriction mice on in vitro tumor growth and adhesion capacity was assessed. Results: Preoperative dietary restriction significantly reduced mRNA expression levels of E-selectin (P = 0.0087) and hepatic tumor load (P = 0.036). Dietary restriction serum did not affect in vitro cell growth but reduced in vitro adhesion of C26 cells to endothelial cells (P = 0.0043). Conclusions: Preoperative dietary restriction reduces hepatic tumor load after injection with tumor cells. Reduced adhesion to endothelial cells and reduced mRNA expression of E-selectin suggest that dietary restriction reduces tumor load by lowering the adhesion of circulating tumor cells to hepatic vascular endothelium.
|Circulating tumor cells, Postoperative inflammation, Surgery, Tumor cell adhesion|
|Journal of Surgical Oncology|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
van Ginhoven, T.M, van den Berg, J.W, Dik, W.A, IJzermans, J.N.M, & de Bruin, R.W.F. (2010). Preoperative dietary restriction reduces hepatic tumor load by reduced E-selectin-mediated adhesion in mice. Journal of Surgical Oncology, 102(4), 348–353. doi:10.1002/jso.21649